Moderna, Inc. (MRNA) income statement
NASDAQ · Healthcare · Biotechnology · 4,700 employees · CEO Stéphane Bancel
- Price
- $221.72 -0.47%
- Market cap
- $88.5B
- Enterprise value
- $88.1B
- Last report
- Q2 '26 filed 2026-07-31
- Next report
- 2026-11-06
Moderna, Inc. (MRNA) reported revenue of $145M for Q2 '26 (+2.1% year on year), operating income of -$815M (-562.1% of revenue) and net income of -$782M. Over the last four quarters revenue was $2.23B.
Income statement
| Income statement | Trend | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.83B | $2.81B | $167M | $221M | $1.86B | $956M | $107M | $142M | $1.02B | $678M | $389M | $145M | |
| Cost of revenue | $2.24B | $929M | $96M | $115M | $514M | $739M | $90M | $119M | $1.01B | $452M | $955M | $93M | |
| Gross profit | -$410M | $1.88B | $71M | $106M | $1.34B | $217M | $17M | $23M | $8M | $226M | -$566M | $52M | |
| Research & development | $1.16B | $1.41B | $1.03B | $1.22B | $1.14B | $1.12B | $856M | $700M | $801M | $775M | $649M | $651M | |
| Sales & marketing | $0 | $204M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| General & administrative | $0 | $266M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Other operating expenses | $0 | $2M | $36M | -$20M | -$7M | -$10M | -$1M | $0 | -$801M | $0 | $0 | $0 | |
| Operating expenses | $1.6B | $1.88B | $1.34B | $1.47B | $1.41B | $1.46B | $1.07B | $930M | $268M | $1.08B | $822M | $867M | |
| Operating income | -$2.01B | $6M | -$1.27B | -$1.36B | -$70M | -$1.25B | -$1.05B | -$907M | -$260M | -$857M | -$1.39B | -$815M | |
| Interest income | $105M | $103M | $120M | $111M | $103M | $91M | $90M | $81M | $73M | $70M | $72M | $67M | |
| Interest expense | $10M | $6M | $6M | $6M | $6M | $6M | $1M | $1M | $0 | $8M | $17M | $0 | |
| Other non-operating income (gains on investments, FX ...) | -$64M | -$70M | -$107M | -$90M | -$97M | -$68M | -$87M | -$90M | -$73M | -$58M | -$71M | -$48M | |
| Total non-operating income | $54M | $64M | $101M | $84M | $91M | $62M | $86M | $89M | $73M | $58M | $54M | $48M | |
| Income before tax | -$1.96B | $70M | -$1.17B | -$1.28B | $21M | -$1.18B | -$964M | -$818M | -$187M | -$799M | -$1.33B | -$767M | |
| Income tax | $1.67B | -$147M | $10M | $0 | $8M | -$64M | $7M | $7M | $13M | $27M | $9M | $15M | |
| Net income | -$3.63B | $217M | -$1.18B | -$1.28B | $13M | -$1.12B | -$971M | -$825M | -$200M | -$826M | -$1.34B | -$782M | |
| EPS (basic) | -$9.53 | $0.57 | -$3.08 | -$3.33 | $0.03 | -$2.91 | -$2.52 | -$2.13 | -$0.51 | -$2.11 | -$3.40 | -$1.96 | |
| EPS (diluted) | -$9.53 | $0.55 | -$3.08 | -$3.33 | $0.03 | -$2.91 | -$2.52 | -$2.13 | -$0.51 | -$2.11 | -$3.40 | -$1.96 | |
| Shares (basic, weighted) | 381M | 381M | 382M | 384M | 385M | 385M | 386M | 388M | 390M | 392M | 395M | 396M | |
| Shares (diluted, weighted) | 381M | 395M | 382M | 384M | 399M | 385M | 386M | 388M | 390M | 392M | 395M | 396M | |
| Depreciation & amortization | $249M | $202M | $36M | $41M | $52M | $60M | $39M | $57M | $52M | $67M | $59M | $63M | |
| EBITDA | -$1.7B | $278M | -$1.12B | -$1.23B | $79M | -$1.12B | -$924M | -$760M | -$135M | -$732M | -$1.26B | -$704M |
| Income statement | Trend | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $108M | $206M | $135M | $60.2M | $803M | $17.7B | $18.9B | $6.85B | $3.2B | $1.94B | |
| Cost of revenue | $15.1M | $20.5M | $24.9M | $31M | $39.2M | $2.62B | $5.42B | $4.69B | $1.46B | $868M | |
| Gross profit | $93.3M | $185M | $110M | $29.2M | $764M | $15.1B | $13.5B | $2.16B | $1.74B | $1.08B | |
| Research & development | $275M | $410M | $454M | $496M | $1.37B | $1.99B | $3.3B | $4.85B | $4.54B | $3.13B | |
| Sales & marketing | $0 | $0 | $0 | $0 | $0 | $0 | $121M | $204M | $146M | $0 | |
| General & administrative | $57.5M | $64.7M | $94.3M | $110M | $0 | $0 | $1.01B | $1.35B | $1.03B | $0 | |
| Other operating expenses | -$15.1M | -$20.5M | -$454M | -$31M | -$31.3M | -$735M | -$388M | $0 | -$37M | $0 | |
| Operating expenses | $317M | $455M | $94.3M | $575M | $1.53B | $1.82B | $4.04B | $6.39B | $5.68B | $4.15B | |
| Operating income | -$224M | -$269M | -$469M | -$546M | -$763M | $13.3B | $9.42B | -$4.24B | -$3.95B | -$3.07B | |
| Interest income | $11.3M | $15.2M | $27M | $38.5M | $24.7M | $18M | $200M | $421M | $425M | $314M | |
| Interest expense | $0 | $132K | $3.1M | $6.61M | $9.89M | $18M | $29M | $38M | $24M | $10M | |
| Other non-operating income (gains on investments, FX ...) | $0 | -$13.5M | -$32M | -$37.6M | -$28.5M | -$7M | -$184M | -$335M | -$362M | -$306M | |
| Total non-operating income | $8.6M | $13.4M | $28.9M | $31M | $18.6M | -$11M | $155M | $297M | $338M | $306M | |
| Income before tax | -$215M | -$256M | -$440M | -$515M | -$745M | $13.3B | $9.58B | -$3.94B | -$3.61B | -$2.77B | |
| Income tax | $1.04M | -$80K | $326K | -$695K | $2.55M | $1.08B | $1.21B | $772M | -$46M | $54M | |
| Net income | -$216M | -$256M | -$385M | -$514M | -$747M | $12.2B | $8.36B | -$4.71B | -$3.56B | -$2.82B | |
| EPS (basic) | -$3.79 | -$0.72 | -$1.17 | -$1.55 | -$1.96 | $30.31 | $21.26 | -$12.34 | -$9.27 | -$7.26 | |
| EPS (diluted) | -$3.79 | -$0.72 | -$1.17 | -$1.55 | -$1.96 | $28.29 | $20.10 | -$12.34 | -$9.27 | -$7.26 | |
| Shares (basic, weighted) | 64.1M | 376M | 329M | 331M | 381M | 403M | 394M | 382M | 384M | 389M | |
| Shares (diluted, weighted) | 64.1M | 376M | 329M | 331M | 381M | 431M | 416M | 382M | 384M | 389M | |
| Depreciation & amortization | $15.1M | $20.5M | $24.9M | $31M | $31M | $232M | $348M | $621M | $189M | $215M | |
| EBITDA | -$209M | -$235M | -$412M | -$477M | -$704M | $13.5B | $9.95B | -$3.28B | -$3.39B | -$2.55B |
Standardised by Financial Modeling Prep from the company's filings; outflows and costs keep the sign the provider reports. Hover a period for its end date. Amounts in USD.
Revenue, operating income and growth
quarterlyMargins
quarterlyCosts as % of revenue
quarterlyThe other statements
Sources
Statements, segment revenue, metrics, estimates: Financial Modeling Prep. Segment profits and every reported line: SEC EDGAR (XBRL). Filings read: 10-Q 2026-06-30, 10-Q 2026-03-31, 10-K 2025-12-31, 10-Q 2025-09-30, 10-Q 2025-06-30, 10-Q 2025-03-31, 10-K 2024-12-31, 10-Q 2024-09-30, 10-Q 2024-06-30
Data as of 2026-11-01